Independent fund research. Built on SEC filings.

How we research funds

ETF · Health Care Sector · iShares

IDNA Holdings: What iShares Genomics Immunology and Healthcare ETF Owns

Ticker IDNA · Since 2019-06-11 · · Holdings as of Jul 31, 2026

Expense ratio
0.47%$47/yr per $10k
5-yr return
−4.8%annualized
1-yr return
−1.0%as of Dec 2024
Net assets
$190.9Mall share classes
Holdings
61

Bottom line

What does IDNA hold?

IDNA held 61 positions as of Jul 31, 2026. Its largest holding is BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares at 10.39% of the fund, and the top 10 positions add up to 49.5%. By asset type it is 96% stocks, 10% cash & short-term funds, 4% other.

Updated Sep 23, 2026

IDNA top 25 holdings

#HoldingType% of fundValue
1 BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares
BLACKROCK CASH FUNDS INSTITUTIONAL FUND SL AGENCY
Cash & short-term funds 10.39%$19.8M
2 Bayer Aktiengesellschaft
BAYER AG
Stocks 4.81%$9.2M
3 Twist Bioscience Corp
TWIST BIOSCIENCE CORP
Stocks 4.79%$9.1M
4 Revolution Medicines, Inc.
REVOLUTION MEDICINES INC
Stocks 4.55%$8.7M
5 Regeneron Pharmaceuticals, Inc.
REGENERON PHARMACEUTICALS INC
Stocks 4.35%$8.3M
6 Genmab A/s
GENMAB A S
Stocks 4.23%$8.1M
7 Incyte Corporation Stocks 4.23%$8.1M
8 Moderna, Inc.
MODERNA INC
Stocks 4.19%$8.0M
9 Takeda Pharmaceutical Company Limited
TAKEDA PHARMACEUTICAL CO LTD
Stocks 4.05%$7.7M
10 Merck & Co., Inc.
MERCK CO INC
Stocks 3.91%$7.5M
11 Vertex Pharmaceuticals Incorporated
VERTEX PHARMACEUTICALS INC
Stocks 3.87%$7.4M
12 Roche Holding AG
ROCHE HOLDING AG
Stocks 3.85%$7.3M
13 Ipsen Sa Stocks 3.84%$7.3M
14 BioNTech SE
BIONTECH SE
Other 3.73%$7.1M
15 Exelixis, Inc.
EXELIXIS INC
Stocks 3.65%$7.0M
16 Gsk Plc Stocks 3.63%$6.9M
17 Sanofi Sa
SANOFI
Stocks 3.46%$6.6M
18 IDEAYA Biosciences Inc
IDEAYA BIOSCIENCES INC
Stocks 3.36%$6.4M
19 Immunitybio Inc
IMMUNITYBIO INC
Stocks 3.07%$5.9M
20 Arcus Biosciences, Inc.
ARCUS BIOSCIENCES INC
Stocks 2.68%$5.1M
21 Caris Life Sciences, Inc.
CARIS LIFE SCIENCES INC
Stocks 2.19%$4.2M
22 Ono Pharmaceutical Co., Ltd.
ONO PHARMACEUTICAL CO LTD
Stocks 1.91%$3.7M
23 Iovance Biotherapeutics Inc
IOVANCE BIOTHERAPEUTICS INC
Stocks 1.80%$3.4M
24 Nuvation Bio Inc.
NUVATION BIO INC
Stocks 1.78%$3.4M
25 CRISPR Therapeutics AG
CRISPR THERAPEUTICS AG
Stocks 1.57%$3.0M

Source: SEC Form N-PORT, period ended Jul 31, 2026, filed Sep 23, 2026

Asset mix

Stocks96.0%
Cash & short-term funds10.5%
Other3.8%

Country exposure

CA1.5%
CH5.4%
CN2.3%
DE8.5%
DK4.2%
FR7.8%
GB3.7%
JP6.0%
KR0.3%
LU0.5%